Vanguard Global Advisers
NNVC icon

Vanguard Global Advisers’s NanoViricides NNVC Stock Holding History

Vanguard Global Advisers’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.12K Hold
3,712
– – ﹤0.01% 3550
2026
Q1 		$3.38K Buy
+3,712
New +$3.88K ﹤0.01% 3585

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Global Advisers's NNVC Position: Q2 2026 in Review

Vanguard Global Advisers held its NanoViricides (NNVC) position steady in Q2 2026 at 3,712 shares worth $5.12K. The position accounts for ﹤0.01% of the portfolio, ranked #3550.

Vanguard Global Advisers first reported a position in NNVC in Q1 2026 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Vanguard Global Advisers held 3,712 shares of NanoViricides worth $5.12K as of Q2 2026.
  • Vanguard Global Advisers left its NanoViricides share count unchanged in Q2 2026.
  • NanoViricides made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3550 holding.
  • Vanguard Global Advisers first reported a position in NanoViricides in Q1 2026 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.